EU funds

PROJECT INFORMATION
Beneficiary: Special Hospital for Ophthalmology Svjetlost
Total project value: EUR 1,521,925.95
Grant awarded: EUR 522,661.20
Project duration: October 1, 2022 – October 1, 2024

The innovative ophthalmic services Retina Lux and Dioptrija Lux are designed for the early detection and prevention of vision loss caused by diabetes, myopia and other refractive errors.

The aim of the project is to modernize Svjetlost’s business processes and business organization in order to bring these services to market. This project is aimed at people with diabetes, people genetically predisposed to myopia, and children and adolescents.

Svjetlost supports and promotes gender equality, equal opportunity and non-discrimination of any kind.

Svjetlost Eye Clinic is accessible to people with disabilities.

In this regard, we declare that all existing and future positions in our organization are open to everyone – people of any gender or background, and people with and without disabilities – who can perform the duties of the role.

We hire on expertise, competence and willingness to learn.

Ivan Gabrić, [email protected], +385 1 7775 656
The content of this publication is the sole responsibility of the Special Hospital for Ophthalmology Svjetlost.